Since entering the aesthetics market in 2006, our knowledge and experience have brought us the trust of the most recognized plastic surgeons worldwide. Keeping training and research as key pillars for our growth, we work with internationally renowned doctors that contribute to the development of our products with their knowledge and expertise.

BioScience GmbH is a German expert in the field of aesthetic medicine. The base of our expertise comes from a comprehensive approach to the manufacturing process of medical devices based on hyaluronic acid for the health industry. Since 2001, we have been pursuing the development of innovative injectable products for various medical specialties, such as dentistry, general surgery, urology, ophthalmology, and orthopedics.

As part of an ongoing alignment to the global standards, BioScience maintains relationships and cooperation with research institutes, key opinion leaders, as well as international societies of aesthetic medicine worldwide.

Mentor was founded in 1969 and has a long, proud history as a global leader in breast aesthetics. For over 30 years, our company has rooted itself in a commitment to high-quality breast implants, science-based innovations, and the best results for patients. We’ve maintained high standards of design, testing and safety, and we’ve earned the respect of the breast aesthetics community worldwide for our leadership. Being a part of the Johnson & Johnson Family of Companies, we aspire to be the trusted partner in breast aesthetics among both consumers and professionals. By providing a broad range of innovation and clinical-based solutions, we aim to help women maintain, enhance, and restore self-esteem and quality of life.

GC Aesthetics (GCA) is an established global medical technology company that develops, manufactures in-house, and markets a comprehensive range of proprietary aesthetic products that empower patients to feel confident and secure in their personal journey. Throughout 40 years of commercial presence, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality products under its premium Nagor and Eurosilicone brands, primarily for breast augmentation and breast reconstructive surgery. More than three million women and men across 70 countries have trusted GCA products, which are supported by published 10-year clinical data demonstrating compelling safety and clinical effectiveness. The Company’s vertically integrated strategy enables exceptional clinical, operational and commercial performance, which allows GCA to provide competitively differentiated products to physicians and patients. Through a culture of continuous innovation and dedication to customer-responsiveness, GCA has established itself as a leading provider of medical aesthetics solutions and the partner-of-choice for patients seeking to improve their lives.

POLYTECH – Quality you can feel

POLYTECH Health & Aesthetics is one of the world’s leading manufacturers of silicone implants. Our success is directly linked with our innovative spirit, commitment to quality, and more than 30 years of experience.

Established in 1986 in Dieburg, Germany, we continue to expand our range of services and constantly develop our products portfolio. Today, reconstructive and aesthetic plastic surgeons from all over the world rely on our implants to perfectly replicate soft tissue in the human body, from breasts to calves.

Our mission has always been to develop tailored solutions for the most varied requirements. Every person is unique, has different wishes and a very personal ideal of beauty. Our implants reflect that. In the field of breast implants alone, we offer more than 2,000 variants, all of them developed to meet the highest safety standards.

Solta Medical®, the aesthetic division of Bausch Health, is a US-based global player in the energy-based body shaping and skin tightening medical aesthetic market. Solta Medical® designs,  manufactures and markets gold standard energy-based medical devices: Thermage®, Vaser®, Fraxel® and Clear+Brilliant®.

THERMAGE® FLX is the latest version and 4TH generation of Thermage® technologies. THERMAGE® FLX is a non-invasive skin tightening treatment that uses capacitively monopolar radiofrequency technology to tighten and smooth the skin on the face, under eyes, eyelids and body, with visible results in a single session.

FRAXEL® DUAL  is a non-ablative fractional laser treatment that improves tone, texture and radiance of ageing, sun-damaged or scarred skin.  Fraxel® treats common skin concerns, including fine lines and periorbital wrinkles, surgical scars, hyperpigmentation, sun damage, and actinic keratosis.

CLEAR+BRILLIANT® is a gentle laser treatment that uses fractional laser technology that addresses and prevents the early signs of ageing skin.

VASER®  is a minimally invasive, precise ultrasound-assisted liposuction system that helps refine the silhouette and reveal muscle definition with less postoperative discomfort than traditional liposuction techniques.

GalaFLEX™ Scaffold Internal Bra™ by BD

Committed to developing innovative solutions with P4HB (poly-4-hydroxybutyrate) and delivering predictable strength and stability to surgeons and patients alike.  The GalaFLEX™ Scaffold Collection supports, repairs and reinforces soft tissue in breast surgery procedures. 

Advantages include:

• Strong
• Bioabsorbable
• Biologically Derived
• Monofilament
• Predictable performance

Visit galateasurgicalinternational.com today for important safety information and to learn more about how GalaFLEX™ Scaffold can support you and your breast surgery patients.

IBSA has used its experience and expertise in the pharmaceutical field to branch out and develop medical devices for aesthetic medicine based on hyaluronic acid, thus creating in 2005 a dedicated brand category: IBSA Derma. Through scientific expertise, continuous research, technological development and a modern production process, IBSA has become one of the leading pharmaceutical companies for the production of hyaluronic acid in aesthetic medicine applications.

IBSA Derma distinguishes itself in this vast market because it controls the entire product lifecycle, from the biofermentation production of the raw material to the ready-to-use final product in pre-filled syringes.

IBSA Derma now offers a complete range of products whose production, from research to trading, is completely Italian. The company distributes over 3 million of product packages in over 80 countries with our injective formulations and markets over 160.000 cosmetics inspired by aesthetic medicine1.

The expertise with hyaluronic acid at the heart of our technology

IBSA’s know-how in the production of hyaluronic acid, combined with scientific discoveries on the role of skin aging, has enabled the development of injectable products capable of providing comprehensive clinical responses to both the patient and the healthcare professional.

All the different formulas, including cross-linked ones, are based on the use of hyaluronic acid chains with different molecular weights that perform different actions in the surrounding tissue.

IBSA Derma is therefore able to offer customized solutions tailored to the specific needs of each individual. Knowing how to distinguish and choose hyaluronic acid products enables practitioners to maximize results in aesthetic medicine treatments, helping to improve people’s quality of life and preserve their authentic beauty.